📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Sodium-glucose cotransporter 2 inhibition does not reduce hepatic steatosis in overweight, insulin-resistant patients without type 2 diabetes. (2020)

First Author: Marjot T

Attributed to: Dissecting the steroid metabolome in the pathogenesis and treatment of metabolic liver disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/jgh3.12274

PubMed Identifier: 32514450

Publication URI: http://europepmc.org/abstract/MED/32514450

Type: Journal Article/Review

Volume: 4

Parent Publication: JGH open : an open access journal of gastroenterology and hepatology

Issue: 3

ISSN: 2397-9070